FUNCTIONALLY-MODIFIED OLIGONUCLEOTIDES AND SUBUNITS THEREOF
申请人:Sarepta Therapeutics, Inc.
公开号:US20140330006A1
公开(公告)日:2014-11-06
Functionally-modified oligonucleotide analogues comprising modified intersubunit linkages and/or modified 3′ and/or 5′-end groups are provided. The disclosed compounds are useful for the treatment of diseases where inhibition of protein expression or correction of aberrant mRNA splice products produces beneficial therapeutic effects.
12-, 15-, and 18-Membered-ring nitrogen-pivot lariat ethers: syntheses, properties, and sodium and ammonium cation binding properties
作者:Rose Ann Schultz、Banita D. White、Dennis M. Dishong、Kristin A. Arnold、George W. Gokel
DOI:10.1021/ja00309a039
日期:1985.11
Preparation de pres de 50 etherslariat par cyclisation d'une amine ou d'un diol convenablement substitue. Formation de complexes avec lesions Na et NH 4
制备 de pres de 50 ethers lariat par cyclisation d'une amine ou d'un diol convenablement substitue。形成复合物 avec 病变 Na et NH 4
Effect of chain length and heteroatom position on ammonium ion binding in nitrogen-containing ‘lariat’ ethers
作者:Rose Ann Schultz、Eric Schlegel、Dennis M. Dishong、George W. Gokel
DOI:10.1039/c39820000242
日期:——
Macrocuclic polyethers having polyethyleneoxy-sidechains extending from a nitrogen pivot bind ammoniumions quite strongly when an 18-memebered ring and a two-oxygen sidechain are present; a 15-memebered ring and other chainlengths give inferior binding.
The formation of complexes between aza derivatives of crown ethers and primary alkylammonium salts. Part 1. Monoaza derivatives
作者:Martin R. Johnson、Ian O. Sutherland、Roger F. Newton
DOI:10.1039/p19790000357
日期:——
The monoaza derivatives of crown ethers form complexes with primaryalkylammonium thiocyanates analogous to those formed by the crown ethers. The n.m.r. spectra of the complexes show temperature dependence which can be analysed in terms of various types of guest exchange processes and conformational changes of the host molecules. In particular, rapid conformational changes of the host macrocycle, accompanied
The present invention provides novel dihydropyrancarboxamide compounds of formula (I):
and collections of these compounds, and provides methods for the synthesis of these compounds; wherein R
1
-R
6
are as defined herein. Additionally, the present invention provides pharmaceutical compositions and methods for treating disorders such as proliferative diseases, and cancer, to name a few.